Drawing for CHARDON PHARMA

USPTO serial 79110588

CHARDON PHARMA

Reviewed by CopyMark Law Group

Reg. 4437861Status 404
Filing date
Status date
Registration date
Nov 26, 2013
Examiner
IN, SUNG HYUN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHARDON PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Biotechnological, chemical and pharmacological laboratory services, including scientific and technological research relating to the production of pharmaceutical and veterinary preparations and expert consultancy thereon; conducting timely appraisals in the field of new medicines, as part of scientific research, namely, basic, clinical and laboratory research in the field of brain disorder science and medicine; development of pharmaceutical preparations, medicines and medicaments; technological services in the pharmaceutical and health care sectors, namely, scientific laboratory services; appraisal of pharmaceutical preparations as part of scientific analysis and research, namely, basic, clinical and laboratory research in the field of brain disorder science and medicine research; scientific research and development in the pharmaceutical field; scientific research and development in this regard, all relating to medicines, and the preparation of test preparations in connection with product development, namely, scientific research and development; scientific research in the medical sectorSECTION 71 - CANCELLED—
044Preparation of medicines and pharmaceutical preparations, namely, pharmacists' services to make up prescriptions; medical examinations of patients; veterinary servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 19, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 22, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 20, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 20, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Dec 18, 2018CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 14, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 13, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 26, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 5, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 13, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 27, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 26, 2014FIMPFINAL DISPOSITION PROCESSED—
Feb 26, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 26, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2013GPNXNOTIFICATION PROCESSED BY IB—
Sep 10, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 28, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 21, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 6, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 2, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 2, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Aug 2, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 2, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 2, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 4, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2012ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 4, 2012PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 24, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 17, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2012DMCCDATA MODIFICATION COMPLETED—
Oct 17, 2012ALIEASSIGNED TO LIE—
Oct 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2012RFNTREFUSAL PROCESSED BY IB—
Apr 18, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 18, 2012RFRRREFUSAL PROCESSED BY MPU—
Apr 18, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 17, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 11, 2012DOCKASSIGNED TO EXAMINER—
Apr 11, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 10, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance